XU Duo-rong, ZOU Wai-yi, XU Hui-ru, et al. Serum level of monocyte chemoattractant protein-2 cant be used as an indicator for identifying acute graft-versus-host disease or infection at the early stage after Allo-HSCT[J]. ORGAN TRANSPLANTATION, 2011, 02(5): 253-256. doi: 10.3969/j.issn.1674-7445.2011.05.004
| Citation:
|
XU Duo-rong, ZOU Wai-yi, XU Hui-ru, et al. Serum level of monocyte chemoattractant protein-2 cant be used as an indicator for identifying acute graft-versus-host disease or infection at the early stage after Allo-HSCT[J]. ORGAN TRANSPLANTATION, 2011, 02(5): 253-256. doi: 10.3969/j.issn.1674-7445.2011.05.004
|
XU Duo-rong, ZOU Wai-yi, XU Hui-ru, et al. Serum level of monocyte chemoattractant protein-2 cant be used as an indicator for identifying acute graft-versus-host disease or infection at the early stage after Allo-HSCT[J]. ORGAN TRANSPLANTATION, 2011, 02(5): 253-256. doi: 10.3969/j.issn.1674-7445.2011.05.004
| Citation:
|
XU Duo-rong, ZOU Wai-yi, XU Hui-ru, et al. Serum level of monocyte chemoattractant protein-2 cant be used as an indicator for identifying acute graft-versus-host disease or infection at the early stage after Allo-HSCT[J]. ORGAN TRANSPLANTATION, 2011, 02(5): 253-256. doi: 10.3969/j.issn.1674-7445.2011.05.004
|
Serum level of monocyte chemoattractant protein-2 cant be used as an indicator for identifying acute graft-versus-host disease or infection at the early stage after Allo-HSCT
DownLoad: